foot ulcer

PolarityTE Inc (NASDAQ: PTE) has announced final data from a trial evaluating SkinTE plus standard of care (SOC) vs. SOC alone for Diabetic Foot Ulcers. The trial met the primary endpoint of wound closure at 12 weeks and the secondary endpoint of Percent Area Reduction (PAR),...